The cohort was divided into three groups, comprising CP donors who did not develop a humoral response and accordingly were Ab−, Ab+ CP donors presented with mild disease and thus were not hospitalized, and Ab+ CP donors previously hospitalized due to severe COVID-19 symptoms. The gene discussed is CP; the disease is COVID-19.